Angiotensin-Converting Enzyme Inhibition and/or Angiotensin Receptor Blockade Modulate Cytokine Profiles and Improve Clinical Outcomes in Experimental COVID-19 Infection.

Int J Mol Sci · 2025 · PMC12387000 · PMID 40868984

Europe PMC DOI

hedged sentence

0.1214

closest p · 2.4× alpha

0.1214

boldest claim

The sentences

did not reach statistical significancep = 0.1214not close (p > 0.1)

Although the Losartan-treated Infected group exhibited a trend toward lower mortality, this difference did not reach statistical significance ( p = 0.1214).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.